Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.
J Thorac Oncol. 2016 Sep;11(9):1453-9. doi: 10.1016/j.jtho.2016.05.026. Epub 2016 Jun 8.
How long persistent and stable ground-glass nodules (GGNs) should be followed is uncertain, although a minimum of 3 years is suggested. Here, we evaluated a group of GGNs that had remained stable for an initial period of 3 years with the aim of determining the proportion of GGNs showing subsequent growth after the initial 3 years and identifying the clinical and radiologic factors associated with subsequent growth.
We retrospectively analyzed patients who underwent further computed tomography (CT) after the initial 3-year follow-up period showing a persistent and stable GGN (at least 5 years of follow-up from the initial CT).
Between May 2003 and June 2015, 453 GGNs (438 pure GGNs and 15 part-solid GGNs) were found in 218 patients. Of the 218 patients, 14 had 15 GGNs showing subsequent growth after the initial 3 years during the median follow-up period of 6.4 years. For the person-based analysis, the frequency of subsequent growth of GGNs that had been stable during the initial 3 years was 6.7% (14 of 218). For the nodule-based analysis, the frequency was 3.3% (15 of 453). In a multivariate analysis, age 65 years or older (OR = 5.51, p = 0.012), history of lung cancer (OR = 6.44, p = 0.006), initial size 8 mm or larger (OR = 5.74, p = 0.008), presence of a solid component (OR = 16.58, p = 0.009), and air bronchogram (OR = 5.83, p = 0.015) were independent risk factors for subsequent GGN growth.
For the individuals with GGNs having the aforementioned risk factors, the longer follow-up period is required to confirm subsequent GGN growth.
持续稳定的磨玻璃结节(GGN)需要随访多久尚不确定,尽管建议至少随访 3 年。在此,我们评估了一组在最初 3 年稳定的 GGN,旨在确定在最初 3 年后出现 GGN 生长的比例,并确定与后续生长相关的临床和影像学因素。
我们回顾性分析了在最初 3 年随访后进一步进行 CT 检查的患者,这些患者的 GGN 持续存在且稳定(从最初 CT 开始至少随访 5 年)。
2003 年 5 月至 2015 年 6 月,在 218 例患者中发现了 453 个 GGN(438 个纯 GGN 和 15 个部分实性 GGN)。在这 218 例患者中,有 14 例患者在中位随访 6.4 年期间有 15 个 GGN 在最初 3 年后出现生长。对于个体为基础的分析,在最初 3 年稳定的 GGN 发生生长的频率为 6.7%(218 例中有 14 例)。对于结节为基础的分析,频率为 3.3%(453 个中有 15 个)。在多变量分析中,年龄 65 岁或以上(OR=5.51,p=0.012)、肺癌病史(OR=6.44,p=0.006)、初始大小为 8mm 或更大(OR=5.74,p=0.008)、存在实性成分(OR=16.58,p=0.009)和空气支气管征(OR=5.83,p=0.015)是 GGN 后续生长的独立危险因素。
对于具有上述危险因素的 GGN 患者,需要进行更长时间的随访以确认 GGN 生长。